This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

8 More ETFs Join Deathwatch in December

NEW YORK ( TheStreet) -- Eight new names are joining ETF Deathwatch for December, and nine products are coming off the list.

Six are leaving due to increased investor interest, and three ETFs are exiting because they are now dead, delisted, and liquidated. ETF Deathwatch now consists of 374 (274 ETFs and 100 ETNs) names from the 1,445 listed for trading.

Even though there is a risk these exchange-traded products (ETPs) could eventually close, liquidity risk is present today. For example, the iPath US Treasury 5-Year Yield Bull (DFVL) hasn't traded since Sept. 13. It is just one of eight Zombie products going the entire month of November with zero volume.

iPath Short Enhanced MSCI EAFE (MFSA) is quoted Friday with a bid price of $37.14 and an ask of $112.10 (a spread of $74.96). Even more troubling is the fact that there are only 100 shares available at each end of those extremes.

The average product on ETF Deathwatch is more than 31 months old and has $6.3 million in assets. Sponsor patience varies widely, with some closing non-profitable products within their first year while others seem willing to subsidize products forever.

There are currently 44 exchange-traded funds and exchanged-traded notes on the list that have been on the market for more than five years. The quantity of funds with less than $2 million in assets stands at 60.

The complete list of 374 products on ETF Deathwatch for December 2012 can be found here .

The ETPs added to ETF Deathwatch for December:

    1. AdvisorShares Global Echo ETF (GIVE)

    2. AlphaClone Alternative Alpha ETF (ALFA)

    3. Credit Suisse Merger Arbitrage Liquid 2x Monthly ETN (CSMB)

    4. C-Tracks Citi Volatility Index Total Return ETN (CVOL)

    5. Guggenheim S&P Equal Weight Financials (RYF)

    6. iShares MSCI Denmark Capped Investable Market (EDEN)

    7. QuantShares U.S. Market Neutral Value (CHEP)

    8. SPDR S&P 400 Mid Cap Value ETF (MDYV)

The ETPs removed from ETF Deathwatch due to improved health:

    1. Direxion Daily Healthcare Bull 3x (CURE)

    2. ETRACS DJ-UBS Commodity 2-4-6 Blended Futures ETN (BLND)

    3. iPath Seasonal Natural Gas ETN (DCNG)

    4. iShares Asia/Pacific Dividend 30 (DVYA)

    5. iShares MSCI China Small Cap Index Fund (ECNS)

    6. ProShares Ultra MSCI Europe (UPV)

The ETPs removed from ETF Deathwatch due to death and delisting:

    1. QuantShares U.S. Market Neutral Anti-Momentum (NOMO)

    2. QuantShares U.S. Market Neutral High Beta (BTAH)

    3. QuantShares U.S. Market Neutral Quality (QLT)

At the time of publication the author had no position in any of the stocks mentioned.

This article was written by an independent contributor, separate from TheStreet's regular news coverage.
Ron Rowland is the founder and president of Capital Cities Asset Management, a fee-based registered investment adviser in Austin, Texas. He is also the founder and publisher of Invest With An Edge and All Star Investor, where he has been providing market commentary and active investment advice since 1991. Opinions expressed in this article should not be considered personal recommendations to buy or sell any security.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
TSLA $237.35 -1.80%
YHOO $36.14 -1.10%
AAPL $95.41 1.90%
FB $117.90 -0.57%
GOOG $695.59 -0.38%


Chart of I:DJI
DOW 17,760.49 -130.67 -0.73%
S&P 500 2,063.36 -18.07 -0.87%
NASDAQ 4,773.5830 -44.0110 -0.91%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs